The frequency of possible side effects listed below is determined as follows: very often (> = 1/10); often (> = 1/100 to <1/10); infrequently (> = 1/1000 to <1/100); rarely (> = 1 / 10,000 to <1/1000); very rarely (<1/10000); frequency is unknown (can not be estimated from available data).
Violations from the blood and lymphatic system:
Very rarely: thrombocytopenia, thrombocytopenic purpura, aplastic anemia, pancytopenia.
Rarely: bleeding (including nasal bleeding, gastrointestinal bleeding, bleeding from the urinary tract, etc.).
Immune system disorders:
Infrequent: hypersensitivity reactions.
Very rarely: severe anaphylactic or anaphylactoid reactions occurring within a few minutes after administration of pentoxifylline, Quincke's edema, bronchospasm, anaphylactic shock.
Disorders of the psyche:
Infrequent: increased excitability, insomnia.
Impaired nervous system:
Infrequent: dizziness, tremor, headache.
Very rarely: paresthesia, convulsions, intracranial hemorrhage, aseptic meningitis.
Disorders from the side of the organ of vision:
Infrequent: impaired vision, conjunctivitis.
Very rarely: hemorrhage into the retina of the eye, detachment of the retina of the eye.
Heart Disease:
Infrequent: a violation of the rhythm of the heart, tachycardia.
Rarely: stenocardia, dyspnea.
Vascular disorders:
Often: hyperemia of the skin of the face.
Rarely: lowering blood pressure, peripheral edema.
Very rarely: increased blood pressure.
Disorders from the gastrointestinal tract:
Often: nausea, vomiting, bloating, a feeling of heaviness in the stomach, diarrhea.
Disorders from the liver and bile ducts:
Rarely: intrahepatic cholestasis, increased activity of "hepatic" transaminase.
Disturbances from the skin and subcutaneous tissues:
Infrequent: itchy skin, erythema, urticaria.
Very rarely: toxic epidermal necrolysis, Stephen-Johnson syndrome, increased sweating.
General disorders and disorders at the site of administration:
Infrequent: increased body temperature.